316 related articles for article (PubMed ID: 20185928)
21. Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects.
López-Hernández FJ; López-Novoa JM
Cell Tissue Res; 2012 Jan; 347(1):141-54. PubMed ID: 22105921
[TBL] [Abstract][Full Text] [Related]
22. Btg2 Promotes Focal Segmental Glomerulosclerosis via Smad3-Dependent Podocyte-Mesenchymal Transition.
Dan Hu Q; Wang HL; Liu J; He T; Tan RZ; Zhang Q; Su HW; Kantawong F; Lan HY; Wang L
Adv Sci (Weinh); 2023 Nov; 10(32):e2304360. PubMed ID: 37749872
[TBL] [Abstract][Full Text] [Related]
23. Apoptosis in podocytes induced by TGF-beta and Smad7.
Schiffer M; Bitzer M; Roberts IS; Kopp JB; ten Dijke P; Mundel P; Böttinger EP
J Clin Invest; 2001 Sep; 108(6):807-16. PubMed ID: 11560950
[TBL] [Abstract][Full Text] [Related]
24. An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas.
Nickl-Jockschat T; Arslan F; Doerfelt A; Bogdahn U; Bosserhoff A; Hau P
Int J Oncol; 2007 Feb; 30(2):499-507. PubMed ID: 17203233
[TBL] [Abstract][Full Text] [Related]
25. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
[TBL] [Abstract][Full Text] [Related]
26. Differential role of mesangial cells and podocytes in TGF-beta-induced mesangial matrix synthesis in chronic glomerular disease.
Lee HS; Song CY
Histol Histopathol; 2009 Jul; 24(7):901-8. PubMed ID: 19475536
[TBL] [Abstract][Full Text] [Related]
27. How many ways can a podocyte die?
Tharaux PL; Huber TB
Semin Nephrol; 2012 Jul; 32(4):394-404. PubMed ID: 22958494
[TBL] [Abstract][Full Text] [Related]
28. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
[TBL] [Abstract][Full Text] [Related]
29. [Transforming growth factor-beta: a new approach to the pathogenesis of glomerulonephritis and glomerulosclerosis].
Witowski J; Knapowski J
Przegl Lek; 1995; 52(9):467-73. PubMed ID: 8834649
[TBL] [Abstract][Full Text] [Related]
30. E pluribus unum: The riddle of focal segmental glomerulosclerosis.
Meyrier A
Semin Nephrol; 2003 Mar; 23(2):135-40. PubMed ID: 12704573
[TBL] [Abstract][Full Text] [Related]
31. The motor protein Myo1c regulates transforming growth factor-β-signaling and fibrosis in podocytes.
Arif E; Solanki AK; Srivastava P; Rahman B; Tash BR; Holzman LB; Janech MG; Martin R; Knölker HJ; Fitzgibbon WR; Deng P; Budisavljevic MN; Syn WK; Wang C; Lipschutz JH; Kwon SH; Nihalani D
Kidney Int; 2019 Jul; 96(1):139-158. PubMed ID: 31097328
[TBL] [Abstract][Full Text] [Related]
32. Mechanical strain increases SPARC levels in podocytes: implications for glomerulosclerosis.
Durvasula RV; Shankland SJ
Am J Physiol Renal Physiol; 2005 Sep; 289(3):F577-84. PubMed ID: 16093428
[TBL] [Abstract][Full Text] [Related]
33. Pediatric nephrotic syndrome: from the simple to the complex.
Lane JC; Kaskel FJ
Semin Nephrol; 2009 Jul; 29(4):389-98. PubMed ID: 19615560
[TBL] [Abstract][Full Text] [Related]
34. Genetic podocyte lineage reveals progressive podocytopenia with parietal cell hyperplasia in a murine model of cellular/collapsing focal segmental glomerulosclerosis.
Suzuki T; Matsusaka T; Nakayama M; Asano T; Watanabe T; Ichikawa I; Nagata M
Am J Pathol; 2009 May; 174(5):1675-82. PubMed ID: 19359523
[TBL] [Abstract][Full Text] [Related]
35. Transforming growth factor-beta and the glomerular extracellular matrix in renal pathology.
Bruijn JA; Roos A; de Geus B; de Heer E
J Lab Clin Med; 1994 Jan; 123(1):34-47. PubMed ID: 8288959
[TBL] [Abstract][Full Text] [Related]
36. [Interleukin 1, transforming growth factor beta and messenger ribonucleic acid expression during the course of glomerulonephritis and glomerulosclerosis].
Zhao Z
Zhonghua Yi Xue Za Zhi; 1992 Apr; 72(4):195-7, 253. PubMed ID: 1327444
[TBL] [Abstract][Full Text] [Related]
37. Cell-cycle regulatory proteins in the podocyte in collapsing glomerulopathy in children.
Srivastava T; Garola RE; Singh HK
Kidney Int; 2006 Aug; 70(3):529-35. PubMed ID: 16775597
[TBL] [Abstract][Full Text] [Related]
38. [Focal segmental glomerulosclerosis (FSGS). Molecular defects and clinical relevance].
Schiffer M; Haller H
Dtsch Med Wochenschr; 2006 Jul; 131(27):1541-5. PubMed ID: 16817104
[No Abstract] [Full Text] [Related]
39. Podocyte injury is suppressed by 1,25-dihydroxyvitamin D via modulation of transforming growth factor-beta 1/bone morphogenetic protein-7 signalling in puromycin aminonucleoside nephropathy rats.
Xiao HQ; Shi W; Liu SX; Zhang B; Xu LX; Liang XL; Liang YZ
Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):682-9. PubMed ID: 19594554
[TBL] [Abstract][Full Text] [Related]
40. Podocyte autophagic activity plays a protective role in renal injury and delays the progression of podocytopathies.
Zeng C; Fan Y; Wu J; Shi S; Chen Z; Zhong Y; Zhang C; Zen K; Liu Z
J Pathol; 2014 Oct; 234(2):203-13. PubMed ID: 24870816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
